head of research impact and communications at Diabetes UK
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Cited on
“These encouraging findings show that this new class of drug for type 2 diabetes could deliver dual benefits for both weight loss and blood-sugar management.”
head of research impact and communications at Diabetes UK · Diabetes · 27 Aug 2026 · Triple-action diabetes jab shown to reduce blood sugar and body weight ↗
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.